Meperidine is named as an intervention in 3 current clinical trials in our Turkey and Singapore registers. None are recruiting at the moment. The most common phase is Not applicable. The sponsor with the most trials is Istanbul Medipol University Hospital (2). The most-studied condition is Postoperative Pain After Arthroscopic Knee Surgery.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Quadro-Iliac Plane Block for Pain Control After Posterior Spinal Instrumentation Surgery
NCT07711522 · ClinicalTrials.gov ↗ · Posterior Spinal Instrumentation Patients
|
Phase EARLY_PHASE1 | Not yet open | Istanbul Medipol University Hospital | Turkey |
|
Adductor Canal Block Versus Parasartorial Compartment Block for Pain Relief and Recovery After Arthroscopic Knee Surgery
NCT07790393 · ClinicalTrials.gov ↗ · Postoperative Pain After Arthroscopic Knee Surgery
|
Not applicable | Not yet open | Istanbul Medipol University Hospital | Turkey |
|
CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery)
NCT03167905 · ClinicalTrials.gov ↗ · Depression, Postpartum, Analgesia, Obstetrical, Anesthesia, Obstetrical
|
Phase 2/3 | Active, closed | KK Women's and Children's Hospital | Singapore |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
The same active substance in our other registers, matched by its exact name. Each entry links to the register record it comes from.
| Lead sponsor | Trials |
|---|---|
| Istanbul Medipol University Hospital | 2 |
| KK Women's and Children's Hospital | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Turkey | 2 | 0 |
| Clinical trials in Singapore | 1 | 0 |
A trial with sites in more than one country appears in each of those registers.
3 current trials in our Turkey and Singapore registers name Meperidine as a drug or biological intervention, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Not at the moment. None of the 3 trials in our registers is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.
Istanbul Medipol University Hospital (2) and KK Women's and Children's Hospital (1). The number in brackets is how many trials each organisation leads.
The registers we track list 1 entry for Meperidine: US FDA: current. Shortages are product- and country-specific; check with a pharmacist.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Meperidine works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Meperidine works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Meperidine (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 26 Sep 2026.